c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells
10.1038/sj.onc.1203541
Crossref journal-article
Springer Science and Business Media LLC
Oncogene (297)
Bibliography

Ceballos, E., Delgado, M. D., Gutierrez, P., Richard, C., Müller, D., Eilers, M., Ehinger, M., Gullberg, U., & León, J. (2000). c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells. Oncogene, 19(18), 2194–2204.

Authors 9
  1. Eva Ceballos (first)
  2. M Dolores Delgado (additional)
  3. Pilar Gutierrez (additional)
  4. Carlos Richard (additional)
  5. Daniel Müller (additional)
  6. Martin Eilers (additional)
  7. Mats Ehinger (additional)
  8. Urban Gullberg (additional)
  9. Javier León (additional)
References 90 Referenced 55
  1. Adachi J, Ookawa K, Shiseki M, Okazaki T, Tsuchida S, Morishita K and Yokota J . 1996 Cell Growth Differ 7: 879–886
  2. Ahuja H, Bar-Eli M, Arlin Z, Advan-i S, Allen SL, Goldman J, Snyder D, Foti A and Cline M . 1991 J Clin Invest 7: 2042–2047 (10.1172/JCI115234)
  3. Alarcon RM, Rupnow BA, Graeber TG, Knox SJ and Giaccia AJ . 1996 Cancer Res 56: 4315–4319
  4. Alimena G, De Cuia MR, Diverio D, Gastaldi R and Nanni M . 1987 Cancer Genet Cytogenet 26: 39–50 (10.1016/0165-4608(87)90131-2)
  5. Amati B, Alevizopoulos K and Vlach J . 1998 Front Biosci 3: d250–d268 (10.2741/A239)
  6. Amundson SA, Myers TG and Fornace AJ Jr . 1998 Oncogene 17: 3287–3299 (10.1038/sj.onc.1202576)
  7. Bates A and Vousden KH . 1999 Cell Mol Life Sci 55: 28–37 (10.1007/s000180050267)
  8. Beck Z, Bacsi A, Kovacs E, Kiss J, Kiss A, Balogh E, Telek B, Toth FD, Andirko I, Olah E, Udvardy M and Rak K . 1998 Leuk Lymphoma 30: 293–306 (10.3109/10428199809057542)
  9. Bellon T, Lopez-Rodriguez C, Rubio MA, Jochems G, Bernabeu C and Corbi AL . 1994 Eur J Immunol 24: 41–47
  10. Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H and Foekens JA . 1992 Cancer Res 52: 1107–1113
  11. Bi S, Lanza F and Goldman JM . 1993 Leukemia 7: 1840–1845
  12. Blyth K, Terry A, O'Hara M, Baxter EW, Campbell M, Stewart M, Donehower LA, Onions DE, Neil JC and Cameron ER . 1995 Oncogene 10: 1717–1723
  13. Bouchard C, Staller P and Eilers M . 1998 Trends Cell Biol 8: 202–206 (10.1016/S0962-8924(98)01251-3)
  14. Cañelles M, Delgado MD, Hyland KM, Lerga A, Richard C, Dang CV and Leon J . 1997 Oncogene 14: 1315–1327 (10.1038/sj.onc.1200948)
  15. Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp RD and Coffey RJ . 1997 Nat Med 3: 1233–1241 (10.1038/nm1197-1233)
  16. Dang CV . 1999 Mol Cell Biol 19: 1–11 (10.1128/MCB.19.1.1)
  17. Delgado MD, Lerga A, Cañelles M, Gómez-Casares MT and Leon J . 1995 Oncogene 10: 1659–1665
  18. Delgado MD, Vaque JP, Arozarena I, López-Ilasaca MA, Martinez C, Crespo P and León J . 2000 Oncogene 19: 783–790 (10.1038/sj.onc.1203384)
  19. Donzelli M, Bernardi R, Negri C, Prosperi E, Padovan L, Lavialle C, Brison O and Scovassi AI . 1999 Oncogene 18: 439–448 (10.1038/sj.onc.1202309)
  20. Ehinger M, Bergh G, Johnsson E, Gullberg U and Olsson I . 1997 Cell Growth Differ 8: 1127–1137
  21. Ehinger M, Nilsson E, Persson AM, Olsson I and Gullberg U . 1995 Cell Growth Differ 6: 9–17
  22. Eischen CM, Weber JD, Roussel MF, Sherr CJ and Cleveland JL . 1999 Genes Dev 13: 2658–2669 (10.1101/gad.13.20.2658)
  23. Felsher DW and Bishop JM . 1999 Mol Cell 4: 199–207 (10.1016/S1097-2765(00)80367-6)
  24. Feinstein E, Gale RP, Reed J and Canaani E . 1992 Oncogene 7: 1853–1859
  25. Frazier MW, He X, Wang J, Gu Z, Cleveland JL and Zambetti GP . 1998 Mol Cell Biol 18: 3735–3743 (10.1128/MCB.18.7.3735)
  26. Garte SJ . 1993 Crit Rev Oncog 4: 435–449
  27. Gottlieb TM and Oren M . 1996 Biochim Biophys Acta 1287: 77–102 (10.1016/0304-419X(95)00019-C)
  28. Grandori C and Eisenman RN . 1997 Trends Biochem Sci 22: 177–181 (10.1016/S0968-0004(97)01025-6)
  29. Grignani F, Lombardi L, Inghirami G, Sterna SL, Cechova K and Dalla-Favera R . 1990 EMBO J 9: 3913–3922 (10.1002/j.1460-2075.1990.tb07612.x)
  30. Gutierrez MI, Bhatia K, Siwarski D, Wolff L, Magrath IT, Mushinski JF and Huppi K . 1992 Cancer Res 52: 1032–1235
  31. Hagiyama H, Adachi T, Yoshida T, Nomura T, Miyasaka N, Honjo T and Tsubata T . 1999 Oncogene 18: 4091–4098 (10.1038/sj.onc.1202772)
  32. Handa H, Hegde UP, Kotelnikov VM, Mundle SD, Dong LM, Burke P, Rose S, Gaskin F, Raza A and Preisler HD . 1997 Leuk Res 21: 479–489 (10.1016/S0145-2126(97)00006-4)
  33. Hansen R and Oren M . 1997 Curr Op Genet Dev 7: 46–51 (10.1016/S0959-437X(97)80108-6)
  34. Henriksson M and Lüscher B . 1996 Adv Cancer Res 68: 109–182 (10.1016/S0065-230X(08)60353-X)
  35. Hermeking H and Eick D . 1994 Science 265: 2091–2094 (10.1126/science.8091232)
  36. Hermeking H, Funk JO, Reichert M, Ellwart JW and Eick D . 1995 Oncogene 11: 1409–1415
  37. Hoffman B and Liebermann DA . 1998 Oncogene 17: 3351–3357 (10.1038/sj.onc.1202592)
  38. Hsu B, Marin MC, el-Naggar AK, Stephens LC, Brisbay S and McDonnell TJ . 1995 Oncogene 11: 175–179
  39. Hueber AO, Zornig M, Lyon D, Suda T, Nagata S and Evan GI . 1997 Science 278: 1305–1309 (10.1126/science.278.5341.1305)
  40. Hueber A-O and Evan GI . 1998 Trends Genet 14: 364–367 (10.1016/S0168-9525(98)01520-0)
  41. Jackson P, Bos E and Braithwaite AW . 1993 Oncogene 8: 589–597
  42. Jennings BA and Mills KI . 1998 Leuk Res 22: 899–903 (10.1016/S0145-2126(98)00097-6)
  43. Kirch HC, Flaswinkel S, Rumpf H, Brockmann D and Esche H . 1999 Oncogene 18: 2728–2738 (10.1038/sj.onc.1202626)
  44. Kirsch DG and Kastan MB . 1999 J Clin Oncol 17: 3158–3168 (10.1200/JCO.1998.16.9.3158)
  45. Ko LJ and Prives C . 1996 Genes Dev 10: 1054–1072 (10.1101/gad.10.9.1054)
  46. Kobayashi T, Consoli U, Andreeff M, Shiku H, Deisseroth AB and Zhang W . 1995 Oncogene 11: 2311–2316
  47. Kremenetskaya OS, Logacheva NP, Baryshnikov AY, Chumakov PM and Kopnin BP . 1997 Oncol Res 9: 155–166
  48. Law JC, Ritke MK, Yalowich JC, Leder GH and Ferrell RE . 1993 Leuk Res 17: 1045–1050 (10.1016/0145-2126(93)90161-D)
  49. Levine AJ . 1997 Cell 88: 323–331 (10.1016/S0092-8674(00)81871-1)
  50. Littlewood TD, Hancock DC, Danielian PS, Parker MG and Evan GI . 1995 Nucleic Acids Res 23: 1686–1690 (10.1093/nar/23.10.1686)
  51. Lotem J and Sachs L . 1995 Proc Natl Acad Sci USA 92: 9672–9676 (10.1073/pnas.92.21.9672)
  52. Mateyak MK, Obaya AJ, Sedivy JM . 1999 Mol Cell Biol 19: 4672–4683 (10.1128/MCB.19.7.4672)
  53. McGahon AJ, Nishioka WK, Martin SJ, Mahboubi A, Cotter TG and Green DR . 1995 J Biol Chem 270: 22625–22631 (10.1074/jbc.270.38.22625)
  54. Melo JV . 1996 Leukemia 10: 751–756 (10.1021/ef950206z)
  55. Metz T, Harris AW and Adams JM . 1995 Cell 82: 29–36 (10.1016/0092-8674(95)90049-7)
  56. Michalovitz D, Halevy O and Oren M . 1990 Cell 62: 671–680 (10.1016/0092-8674(90)90113-S)
  57. Mitchell KO and El-Deiry WS . 1999 Cell Growth Differ 19: 223–230 (10.1023/A:1020568013953)
  58. Miller D, Miller DJ, Garcia JV and Lynch CM . 1993 Meth Enzymol 217: 581–599 (10.1016/0076-6879(93)17090-R)
  59. Milner J and Medcalf EA . 1990 J Mol Biol 216: 481–484 (10.1016/0022-2836(90)90371-R)
  60. Moberg KH, Tyndall WA and Hall DJ . 1992 Cell Biochem 49: 208–215 (10.1002/jcb.240490213)
  61. Nakai H and Misawa S . 1995 Leuk Lymphoma 19: 213–221 (10.3109/10428199509107891)
  62. Newcomb EW . 1995 Leuk Lymphoma 17: 211–221 (10.1016/0141-6359(95)00002-U)
  63. Peller S, Yona R, Kopilova Y, Prokocimer M, Goldfinger N, Uysal A, Karabulut HG, Tukun A, Bokesoy I, Tuncman G and Rotter V . 1998 Genes Chrom Cancer 21: 2–7 (10.1002/(SICI)1098-2264(199801)21:1<2::AID-GCC2>3.0.CO;2-5)
  64. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL and Ross RH . 1996 Mol Cell Biol 16: 1335–1341 (10.1128/MCB.16.4.1335)
  65. Polyak K, Waldman T, He TC, Kinzler KW and Vogelstein B . 1996 Genes Dev 10: 1945–1952 (10.1101/gad.10.15.1945)
  66. Preisler HD, Agarwal R, Sato H, Singh PK, Wang ZQ and Sandberg AA . 1990 Eur J Cancer 26: 960–965 (10.1016/0277-5379(90)90620-9)
  67. Prokocimer M and Rotter V . 1994 Blood 84: 2391–2411 (10.1182/blood.V84.8.2391.2391)
  68. Ragimov N, Krauskopf A, Navot N, Rotter V, Oren M and Aloni Y . 1993 Oncogene 8: 1183–1193
  69. Reisman D, Elkind NB, Roy B, Beamon J and Rotter V . 1993 Cell Growth Differ 4: 57–65
  70. Roy B, Beamon J, Balint E and Reisman D . 1994 Mol Cell Biol 14: 7805–7815 (10.1128/mcb.14.12.7805-7815.1994)
  71. Rupnow BA, Alarcon RM, Giaccia AJ and Knox J . 1998 Cell Death Differ 5: 141–147 (10.1038/sj.cdd.4400328)
  72. Sakamuro D, Eviner V, Elliott KJ, Showe L, White E and Prendergast GC . 1995 Oncogene 11: 2411–2418
  73. Selvakumaran M, Lin HK, TjinThamSjin R, Reed JC, Liebermann DA and Hoffman B . 1994 Mol Cell Biol 14: 2352–2360 (10.1128/MCB.14.4.2352)
  74. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW . 1997 Cell 88: 593–602 (10.1016/S0092-8674(00)81902-9)
  75. Sheikh MS, Rochefort H and Garcia M . 1995 Oncogene 11: 1899–1905
  76. Sonenshein GE . 1997 J Immunol 158: 1994–1997 (10.4049/jimmunol.158.5.1994)
  77. Stahler F and Roemer K . 1998 Oncogene 17: 3507–3512 (10.1038/sj.onc.1202245)
  78. Stuppia L, Calabrese G, Peila R, Guanciali-Franchi P, Morizio E, Spadano A and Palka G . 1997 Cancer Genet Cytogenet 98: 28–35 (10.1016/S0165-4608(96)00413-X)
  79. Subler MA, Martin DW and Deb S . 1992 J Virol 66: 4757–4762 (10.1128/jvi.66.8.4757-4762.1992)
  80. Taylor WR, Egan SE, Mowat M, Greenberg AH and Wright JA . 1992 Oncogene 7: 1383–1390
  81. Thompson EB . 1998 Annu Rev Physiol 60: 575–600 (10.1146/annurev.physiol.60.1.575)
  82. Trepel M, Scheding S, Groscurth P, Horny HP, Malipiero U, Brugger W, Dichgans J and Weller M . 1997 Leukemia 11: 1842–1849 (10.1038/sj.leu.2400824)
  83. Trudel M, Lanoix J, Barisoni L, Blouin MJ, Desforges M, L'Italien C and D'Agati V . 1997 J Exp Med 186: 1873–18784 (10.1084/jem.186.11.1873)
  84. Waikel RL, Wang X-J and Roop DR . 1999 Oncogene 18: 4870–4878 (10.1038/sj.onc.1203040)
  85. Wagner AJ, Kokontis JM and Hay N . 1994 Genes Dev 8: 2817–2830 (10.1101/gad.8.23.2817)
  86. Wallace-Brodeur RR and Lowe SW . 1999 Cell Mol Life Sci 54: 64–75 (10.1007/s000180050270)
  87. Wu R, Bellas RE, Shen J and Sonenshein GE . 1998 J Exp Med 187: 1671–1679 (10.1084/jem.187.10.1671)
  88. Yin XY, Crove L, Datta NS, Long MW and Prochownik EV . 1999 Oncogene 18: 1177–1184 (10.1038/sj.onc.1202410)
  89. Zeng Y-X and El-Deiry . 1996 Oncogene 12: 1557–1564
  90. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF . 1998 Genes Dev 12: 2424–2433 (10.1101/gad.12.15.2424)
Dates
Type When
Created 22 years, 11 months ago (Sept. 4, 2002, 3:45 p.m.)
Deposited 2 years, 4 months ago (April 20, 2023, 8:53 p.m.)
Indexed 1 month, 1 week ago (July 16, 2025, 9:36 a.m.)
Issued 25 years, 3 months ago (April 27, 2000)
Published 25 years, 3 months ago (April 27, 2000)
Published Online 25 years, 3 months ago (May 15, 2000)
Published Print 25 years, 3 months ago (April 27, 2000)
Funders 0

None

@article{Ceballos_2000, title={c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells}, volume={19}, ISSN={1476-5594}, url={http://dx.doi.org/10.1038/sj.onc.1203541}, DOI={10.1038/sj.onc.1203541}, number={18}, journal={Oncogene}, publisher={Springer Science and Business Media LLC}, author={Ceballos, Eva and Delgado, M Dolores and Gutierrez, Pilar and Richard, Carlos and Müller, Daniel and Eilers, Martin and Ehinger, Mats and Gullberg, Urban and León, Javier}, year={2000}, month=apr, pages={2194–2204} }